On October 27, 2026, a clinical trial titled "TEAS for Gastrectomy Recovery" was listed with a status of recruiting. The trial, registered as NCT07898293, involves vasoactive intestinal peptide, which carries an approved regulatory status. The trial phase is listed as not applicable. The listing on ClinicalTrials.gov indicates that enrollment is currently open for this study. No outcome measures, enrollment numbers, or interim findings have been reported for this trial at this stage. The study record does not provide additional details regarding sponsor information, eligibility criteria, or estimated completion dates beyond the current recruiting status. This update reflects only the current listed status of the trial as of the stated date. Readers interested in the study can track future updates through its official registry page as the trial progresses. For additional context on vasoactive intestinal peptide, including its regulatory background and general profile, readers can consult the compound overview.
Trial Update: "TEAS for Gastrectomy Recovery" Now Recruiting
See the full vasoactive intestinal peptide overview
Source: https://clinicaltrials.gov/study/NCT07898293